The Progressive Supranuclear Palsy Clinical Trial Platform
Status:
NOT_YET_RECRUITING
Trial end date:
2029-07-31
Target enrollment:
Participant gender:
Summary
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.
Phase:
PHASE2
Details
Lead Sponsor:
Adam Boxer
Collaborators:
Alzheimer's Clinical Trials Consortium Alzheimer's Therapeutic Research Institute Massachusetts General Hospital National Institute on Aging (NIA) University of California, San Diego University of Southern California